Cerus SG&A Expenses 2010-2024 | CERS
Cerus Annual SG&A Expenses (Millions of US $) |
|
---|---|
2023 | $76 |
2022 | $83 |
2021 | $81 |
2020 | $67 |
2019 | $66 |
2018 | $57 |
2017 | $53 |
2016 | $49 |
2015 | $46 |
2014 | $38 |
2013 | $30 |
2012 | $26 |
2011 | $23 |
2010 | $22 |
2009 | $22 |
Cerus Quarterly SG&A Expenses (Millions of US $) |
|
---|---|
2024-06-30 | $19 |
2024-03-31 | $20 |
2023-12-31 | $17 |
2023-09-30 | $16 |
2023-06-30 | $21 |
2023-03-31 | $22 |
2022-12-31 | $23 |
2022-09-30 | $20 |
2022-06-30 | $20 |
2022-03-31 | $21 |
2021-12-31 | $22 |
2021-09-30 | $20 |
2021-06-30 | $20 |
2021-03-31 | $19 |
2020-12-31 | $19 |
2020-09-30 | $16 |
2020-06-30 | $16 |
2020-03-31 | $16 |
2019-12-31 | $17 |
2019-09-30 | $16 |
2019-06-30 | $17 |
2019-03-31 | $16 |
2018-12-31 | $15 |
2018-09-30 | $14 |
2018-06-30 | $14 |
2018-03-31 | $14 |
2017-12-31 | $13 |
2017-09-30 | $12 |
2017-06-30 | $14 |
2017-03-31 | $14 |
2016-12-31 | $13 |
2016-09-30 | $12 |
2016-06-30 | $12 |
2016-03-31 | $12 |
2015-12-31 | $11 |
2015-09-30 | $11 |
2015-06-30 | $12 |
2015-03-31 | $12 |
2014-12-31 | $11 |
2014-09-30 | $9 |
2014-06-30 | $10 |
2014-03-31 | $8 |
2013-12-31 | $7 |
2013-09-30 | $8 |
2013-06-30 | $8 |
2013-03-31 | $7 |
2012-12-31 | $7 |
2012-09-30 | $6 |
2012-06-30 | $7 |
2012-03-31 | $6 |
2011-12-31 | $6 |
2011-09-30 | $5 |
2011-06-30 | $6 |
2011-03-31 | $6 |
2010-12-31 | $6 |
2010-09-30 | $5 |
2010-06-30 | $5 |
2010-03-31 | $5 |
2009-12-31 | $5 |
2009-09-30 | $5 |
2009-06-30 | $5 |
2009-03-31 | $6 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.330B | $0.156B |
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $199.879B | 25.82 |
Stryker (SYK) | United States | $137.705B | 32.18 |
Boston Scientific (BSX) | United States | $121.595B | 37.03 |
Medtronic (MDT) | Ireland | $113.026B | 16.82 |
EssilorLuxottica (ESLOY) | France | $104.378B | 0.00 |
Haleon (HLN) | United Kingdom | $48.118B | 35.17 |
Lonza Group Ag (LZAGY) | Switzerland | $45.437B | 0.00 |
ResMed (RMD) | United States | $34.974B | 30.79 |
Koninklijke Philips (PHG) | Netherlands | $29.016B | 22.05 |
Terumo (TRUMY) | Japan | $27.876B | 39.37 |
Zimmer Biomet Holdings (ZBH) | United States | $21.644B | 13.63 |
Baxter (BAX) | United States | $20.086B | 13.62 |
Insulet (PODD) | United States | $16.555B | 69.65 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.426B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.489B | 31.44 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
BellRing Brands (BRBR) | United States | $7.672B | 32.44 |
Lantheus Holdings (LNTH) | United States | $7.508B | 18.02 |
ICU Medical (ICUI) | United States | $4.304B | 41.08 |
TG Therapeutics (TGTX) | United States | $3.909B | 41.39 |
Haemonetics (HAE) | United States | $3.870B | 19.14 |
Perrigo (PRGO) | Ireland | $3.841B | 12.14 |
GN Store Nord (GNNDY) | Denmark | $3.758B | 22.64 |
Neogen (NEOG) | United States | $3.736B | 39.18 |
Prestige Consumer Healthcare (PBH) | United States | $3.644B | 18.16 |
Envista Holdings (NVST) | United States | $3.298B | 17.60 |
QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
Agios Pharmaceuticals (AGIO) | United States | $2.591B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.311B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.171B | 36.43 |
LeMaitre Vascular (LMAT) | United States | $1.996B | 53.20 |
AdaptHealth (AHCO) | United States | $1.524B | 11.00 |
InMode (INMD) | Israel | $1.466B | 9.34 |
Warby Parker (WRBY) | United States | $1.466B | 0.00 |
AtriCure (ATRC) | United States | $1.363B | 0.00 |
Owens & Minor (OMI) | United States | $1.219B | 9.41 |
Verano Holdings (VRNOF) | United States | $1.114B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.094B | 0.00 |
Evolus (EOLS) | United States | $1.023B | 0.00 |
PetIQ (PETQ) | United States | $0.920B | 23.32 |
Phibro Animal Health (PAHC) | United States | $0.897B | 18.61 |
National Vision Holdings (EYE) | United States | $0.864B | 27.48 |
Cresco Labs (CRLBF) | United States | $0.801B | 0.00 |
Surmodics (SRDX) | United States | $0.561B | 119.09 |
Quanterix (QTRX) | United States | $0.543B | 0.00 |
ZimVie (ZIMV) | United States | $0.454B | 42.23 |
VAREX IMAGING (VREX) | United States | $0.451B | 13.62 |
Valneva SE (VALN) | France | $0.422B | 0.00 |
Canopy Growth (CGC) | Canada | $0.406B | 0.00 |
Jin Medical (ZJYL) | China | $0.397B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.333B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.321B | 8.29 |
Aurora Cannabis (ACB) | Canada | $0.320B | 0.00 |
Biote (BTMD) | United States | $0.319B | 14.70 |
Viemed Healthcare (VMD) | United States | $0.287B | 30.79 |
Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
Zynex (ZYXI) | United States | $0.260B | 45.44 |
Utah Medical Products (UTMD) | United States | $0.234B | 15.52 |
Ayr Wellness (AYRWF) | United States | $0.232B | 0.00 |
Omeros (OMER) | United States | $0.228B | 0.00 |
MacroGenics (MGNX) | United States | $0.207B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
High Tide (HITI) | Canada | $0.170B | 70.33 |
Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
FitLife Brands (FTLF) | United States | $0.153B | 20.62 |
Brainsway (BWAY) | Israel | $0.140B | 168.00 |
TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.125B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.124B | 0.00 |
Veru (VERU) | United States | $0.113B | 0.00 |
Fonar (FONR) | United States | $0.110B | 11.15 |
Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 24.20 |
InterCure (INCR) | Israel | $0.085B | 14.31 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.075B | 0.00 |
Modular Medical (MODD) | United States | $0.073B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.056B | 3.63 |
Exagen (XGN) | United States | $0.049B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Apyx Medical (APYX) | United States | $0.036B | 0.00 |
Bright Green (BGXX) | United States | $0.028B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.019B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
Agape ATP (ATPC) | $0.008B | 0.00 | |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 20.47 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |